Bio Saga Blog - A Chronicle of Life Sciences & Informatics

  Is organizing 3 Days Hands on Workshop in Chemoinformatics  18 th  November to 20 th  November 2016.  Chemoinformatics is a rapidly developing branch of chemistry. In the coming days the students who have studied Chemoinformatics will be required not only in India but in foreign countries too! The requirement of trained manpower from the discipline such as Chemistry, Biology and Microbiology is the fuel for the growth of Chemoinformatics. The development of Chemoinformatics needs a workforce with a solid background in chemistry and an expertise of the available computer technology. Application of Chemoinformatics is in areas like Agrochemical, pharmaceutical and biotechnological industries, Computational chemistry and library design groups, Chemical software companies, Database developers, Chemical publishers, In-silico Drug Discovery, Toxicity predictions, ADME prediction of Molecules, Chemicals Vendors , R&D, etc Salient Features of the Work...

While this is very encouraging what's going to be it's impact on the industry on proprietary database vendors? More & more of open database consortia and open curation models are on the offing, with high level of participation from both the academia and the Industry. The European Molecular Biology Laboratory's European Bioinformatics Institute has launched a "vast online database" of genomic-based drug and small molecule information available in an open access format for researchers seeking new therapeutics, according to EMBL-EBI. The ChEMBLdb holds translational information on more than 520,000 small molecules, including data on target binding, the affect these compounds have on cells and organisms, and information about the molecules' absorption, distribution, metabolism, excretion, and toxicity. "The data lie at the heart of translating information from the human genome into successful new drugs in the clinic," EMBL-EBI said this week. EMB...

A leading provider of software for pharmaceutical discovery and development, today announced that the pharmacokinetics , dynamics, and metabolism science board at a top three pharmaceutical company named its software an "application of choice." As pharmaceutical companies face a significant number of patent expirations in the near future, there is a need to become more aggressive in research and development to fill the pipeline, sometimes with reduced R&D staff. Productivity tools in the field of pharmacokinectics , ADMET , chemical data visualization and analysis , etc. that leverage the expertise of the industry's scientific teams. It is believed that the difficulties facing some parts of the pharmaceutical industry will result in greater use of such tools as managers realize that the savings in time and money that can be achieved through their application vastly exceeds the cost of obtaining and learning to use them.